Furthermore, semaglutide treatment resulted in a significantly higher percentage of patients with NASH resolution than placebo in the phase II trial involving patients with NASH [80]
The beverage opportunity is particularly strong because of what GLP-1 users actually need: these medications lower food intake and stimulate electrolyte excretion through the kidneys, users face specific risks of cramping, fatigue, and dehydration, said John Scheer, co-founder and Chief Creative Officer of healthcare and wellbeing branding agency Herman Scheer So its not just about marketing: its about genuine functional demand. GLP-1 friendly products While electrolytes are the key element of the hydration proposition, drinks need to go beyond that
It can help signal fullness, slow digestion, and reduce cravings, which may help patients consume fewer calories throughout the day
Baseline metabolism, age, and how much muscle mass you carry also influence the pace at which semaglutide produces visible results
Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
